Impaired platelet aggregation and increased bleeding time during general anaesthesia with halothane

Area of Science:

• Anesthesiology
• Hematology
• Pharmacology

Background:

• Platelet aggregation is crucial for hemostasis.
• Inhaled anesthetics can potentially affect platelet function.
• Understanding anesthetic effects on coagulation is vital for patient safety.

Purpose of the Study:

• To investigate the effect of halothane, nitrous oxide, and oxygen anesthesia on platelet aggregation.
• To determine if in vitro findings correlate with in vivo observations of bleeding time.

Main Methods:

• Platelet aggregation was measured in vitro using platelet-rich plasma exposed to 1% halothane with nitrous oxide and oxygen.
• Bleeding time was assessed in 10 patients undergoing anesthesia with the same gas mixture.
• Comparison of in vitro aggregation inhibition with in vivo bleeding time.

Main Results:

• A significant correlation was observed between the in vitro inhibition of platelet aggregation and the increased bleeding time in patients.
• Halothane in nitrous oxide and oxygen demonstrated inhibitory effects on platelet aggregation in both in vitro and in vivo settings.
• Failure to observe inhibition in platelet-rich plasma from anesthetized patients was attributed to agent evaporation during sample preparation and analysis.

Conclusions:

• Halothane, when administered with nitrous oxide and oxygen, inhibits platelet aggregation.
• This anesthetic-induced platelet inhibition may contribute to prolonged bleeding times.
• In vitro studies require careful methodology to avoid artifactual results due to anesthetic agent volatility.